Results 1 to 10 of about 25,113 (239)

Burkholderia pseudomallei

Trends in Microbiology
Burkholderia pseudomallei is a Gram negative, facultative intracellular bacterium that resides in the rhizosphere of tropical soils. B. pseudomallei causes melioidosis, which is transmitted by cutaneous entry, ingestion, or inhalation of contaminated soil or water. Infection with B.
J. Sarda Carbasse, I. Schober, J. Koblitz, A. Podstawka, L.C. Reimer   +4 more
  +5 more sources

Melioid meningitis: First reported case of Burkholderia pseudomallei meningitis In Colombia

Clinical Infection in Practice, 2023
Human melioidosis is a serious infectious disease commonly known by being endemic in southeast Asia and northern Australia. It is caused by Burkholderia pseudomallei a non-spore forming gram negative bacillus.
Santiago Sanchez-Pardo, Sebastián Mackenzie-Martinez, Samuel Martinez-Vernaza, Gloria Cecilia Cortés Fraile, Sandra Milena Gualtero Trujillo   +4 more
doaj   +2 more sources

Research on the establishment and application of protein fingerprint spectrum database of Burkholderia pseudomallei in Hainan Province China

New Microbes and New Infections, 2021
Burkholderia pseudomallei (B. pseudomallei) is the etiologic agent of melioidosis. The aim of this study was to establish a SuperSpectrum of B. pseudomallei in Hainan and evaluate its application value in the rapid identification of clinical isolates of ...
M.H. Huang, H. Wu, L.L. Liu, X.M. Wang
doaj   +2 more sources

Genomic diversity and clade clustering of Burkholderia pseudomallei and B. thailandensis prophages with soil-derived phages [PDF]

iScience
Summary: Most studies on bacteriophages (phages) of the Gram-negative bacterium Burkholderia pseudomallei rely on in silico predictions and thus underestimate the true diversity of phages.
Patoo Withatanung, Veerachat Muangsombut, Sujintana Janesomboon, Vanaporn Wuthiekanun, Premjit Amornchai, Sorujsiri Chareonsudjai, Dave J. Baker, Martha R.J. Clokie, Edouard E. Galyov, Ozan Gundogdu, Sunee Korbsrisate   +10 more
doaj   +2 more sources

Burkholderia pseudomallei Laboratory Exposure, Arizona, USA

Emerging Infectious Diseases, 2023
We describe an incidental Burkholderia pseudomallei laboratory exposure in Arizona, USA. Because melioidosis cases are increasing in the United States and B.
Lisa J. Speiser, Erin H. Graf, Maria Teresa Seville, Kai Singbartl, Mary L. Dalton, Denise Harrington, Melissa Kretschmer, Marina Kuljanin, Karen Zabel, Rebecca Sunenshine, Irene Ruberto, Heather Venkat, Thomas E. Grys   +12 more
doaj   +3 more sources

Burkholderia pseudomallei: animal models of infection.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008
A range of animal models of Burkholderia pseudomallei infection have been reported, and the host species differ widely both in their susceptibility to infection and in the pathogenesis of disease.
Atkins, Tim, Bancroft, Gregory J, Cuccui, Jon, Easton, Anna, Haque, Ashraful, Harley, Vicki, Russell, Paul, Sarkar-Tyson, Mitali, Titball, Richard W, Wren, Brendan   +9 more
core   +4 more sources

Pathogenicity and virulence ofBurkholderia pseudomallei

Virulence, 2022
The soil saprophyte, Burkholderia pseudomallei, is the causative agent of melioidosis, a disease endemic in South East Asia and northern Australia. Exposure to B. pseudomallei by either inhalation or inoculation can lead to severe disease. B. pseudomallei rapidly shifts from an environmental organism to an aggressive intracellular pathogen capable of ...
Nicole M. Bzdyl, Clare L. Moran, Justine Bendo, Mitali Sarkar‐Tyson   +3 more
openalex   +4 more sources

Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. [PDF]

PLoS ONE, 2012
Burkholderia pseudomallei is the causative agent of melioidosis and is a major mediator of sepsis in its endemic areas. Because of the low LD(50) via aerosols and resistance to multiple antibiotics, it is considered a Tier 1 select agent by the CDC and ...
Michael E Woodman, Randall G Worth, R Mark Wooten   +2 more
doaj   +3 more sources

Novel approach in treatment of <i>Burkholderia pseudomallei</i> osteomyelitis: salvage therapy with levonadifloxacin. [PDF]

JAC Antimicrob Resist
Gupta N, Agashe V, Soman R, Vidyarthi K, Gupta R, Sen I, Koley M, Veeraraghavan B, Gupta K.   +8 more
europepmc   +3 more sources

Evaluation of an automated molecular diagnostic instrument for direct detection of <i>Burkholderia pseudomallei</i> from clinical specimens. [PDF]

J Med Microbiol
Gassiep I, Glover M, Beecham M, Gorman B, Page M, Stewart J, Harris PNA.   +6 more
europepmc   +2 more sources